Clinical Trials & Research
Search Clinical Trials
Clinical Trials
New Search
| Title | A Combination Study of PF-04449913 (Glasdegib) and Azacitidine In Untreated MDS, AML and CMML Patients (BRIGHT 1012) |
|---|---|
| Disease/Condition | Myelodysplastic Syndrome (MDS),Hematologic Diseases,Oncology (Medical/Hematologic),Leukemia,Neoplasms |
| Description | |
| Eligibility Criteria | Click here for eligibility requirements |
| Principal Investigator | Amit Verma, MD |
| Contact Name | Apoorva Talanki |
| Contact Email | atalanki@montefiore.org |
| Protocol Number | 14-06-415-01 |
| Inclusion/Notes | This Information was obtained from ClinicalTrials.gov |
| Status | Active/Enrolling |
| Adult Clinical Trial | Yes |
| Pediatric Clinical Trial | No |
| Sub-Specialty | Higher Risk Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML), or Chronic Myelomonocytic Leukemia (CMML) |
| Adult, Pediatric, Both | Adult |
